123 related articles for article (PubMed ID: 8258199)
1. Biliary elimination and pharmacokinetics of vinorelbine in micropigs.
Levêque D; Merle-Melet M; Bresler L; Didelot JP; Aymard JP; Wihlm J; Jehl F
Cancer Chemother Pharmacol; 1993; 32(6):487-90. PubMed ID: 8258199
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic profile of vinorelbine, a new semi-synthetic vinca alkaloid, determined by high-performance liquid chromatography.
Levêque D; Jehl F; Quoix E; Monteil H
Xenobiotica; 1993 Nov; 23(11):1325-33. PubMed ID: 8310715
[TBL] [Abstract][Full Text] [Related]
3. The effect of rifampin on the pharmacokinetics of vinorelbine in the micropig.
Leveque D; Wisniewski S; Renault C; Peter JD; Le Corre P; Monteil H; Jehl F
Anticancer Res; 2003; 23(3B):2741-4. PubMed ID: 12894568
[TBL] [Abstract][Full Text] [Related]
4. Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinorelbine in mice as determined by high performance liquid chromatography.
van Tellingen O; Kuijpers AV; Beijnen JH; Nooijen WJ; Bult A
Invest New Drugs; 1993; 11(2-3):141-50. PubMed ID: 8262726
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and preliminary metabolic fate of navelbine in humans as determined by high performance liquid chromatography.
Jehl F; Quoix E; Leveque D; Pauli G; Breillout F; Krikorian A; Monteil H
Cancer Res; 1991 Apr; 51(8):2073-6. PubMed ID: 1849042
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary distribution of vinorelbine in patients with non-small-cell lung cancer.
Levêque D; Quoix E; Dumont P; Massard G; Hentz JG; Charloux A; Jehl F
Cancer Chemother Pharmacol; 1993; 33(2):176-8. PubMed ID: 8261579
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of a new anticancer drug, navelbine, in patients. Comparative study of radioimmunologic and radioactive determination methods.
Boré P; Rahmani R; van Cantfort J; Focan C; Cano JP
Cancer Chemother Pharmacol; 1989; 23(4):247-51. PubMed ID: 2924381
[TBL] [Abstract][Full Text] [Related]
8. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and biliary elimination of temafloxacin in pigs.
Jehl F; Bresler L; Koechlin C; Merle-Melet M; Didelot JP; Hazebroucq J
J Antimicrob Chemother; 1992 Aug; 30(2):189-96. PubMed ID: 1328135
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of [3H]navelbine in patients: comparative pharmacokinetics using radioactive and radioimmunologic determination methods.
Rahmani R; Zhou XJ; Boré P; Van Cantfort J; Focan C; Cano JP
Anticancer Drugs; 1991 Aug; 2(4):405-10. PubMed ID: 1797198
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of antitumor activity of navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude mice.
Tsuruo T; Inaba M; Tashiro T; Yamori T; Ohnishi Y; Ashizawa T; Sakai T; Kobayashi S; Gomi K
Anticancer Drugs; 1994 Dec; 5(6):634-40. PubMed ID: 7888700
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of navelbine after oral administration in the dog and the monkey.
Zhou XJ; Landi H; Breillout F; Rahmani R
Anticancer Drugs; 1993 Aug; 4(4):511-5. PubMed ID: 8400355
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of vinorelbine alone and combined with cisplatin.
Levêque D; Jehl F; Quoix E; Breillout F
J Clin Pharmacol; 1992 Dec; 32(12):1096-8. PubMed ID: 1336784
[TBL] [Abstract][Full Text] [Related]
14. The clinical pharmacokinetics of vinorelbine (Navelbine).
Wargin WA; Lucas VS
Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics of vinorelbine.
Levêque D; Jehl F
Clin Pharmacokinet; 1996 Sep; 31(3):184-97. PubMed ID: 8877249
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of vinorelbine in man.
Marquet P; Lachatre G; Debord J; Eichler B; Bonnaud F; Nicot G
Eur J Clin Pharmacol; 1992; 42(5):545-7. PubMed ID: 1607002
[TBL] [Abstract][Full Text] [Related]
17. [Clinical pharmacokinetics of vinca alkaloids].
Rahmani R; Samak R; Bore P; Cano JP
Bull Cancer; 1988; 75(2):195-200. PubMed ID: 3359064
[TBL] [Abstract][Full Text] [Related]
18. Oral versus intravenous vinorelbine: clinical safety profile.
Gebbia V; Puozzo C
Expert Opin Drug Saf; 2005 Sep; 4(5):915-28. PubMed ID: 16111453
[TBL] [Abstract][Full Text] [Related]
19. Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.
Gomi K; Ohno H; Nomura K; Okabe M; Kobayashi K; Niitani H
Jpn J Cancer Res; 1992 May; 83(5):532-9. PubMed ID: 1618703
[TBL] [Abstract][Full Text] [Related]
20. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
